Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cytopathology : Official Journal of the British Society for Clinical Cytology|January 1, 1993
Use of antibodies against a synthetic peptide of the E6 protein of human papillomavirus (HPV) type 16 for the diagnosis of genital HPV lesionsP Tosi, V Pallini, M Cintorino, et al.
Journal of Submicroscopic Cytology and Pathology|July 1, 1989
Expression of actin isoforms and intermediate filament proteins in childhood orbital rhabdomyosarcomasM Cintorino, C Vindigni, M T Del Vecchio, et al.
International Journal of Cancer|June 9, 1995
Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth patternL Leoncini, M T Del Vecchio, D Spina, et al.
The Prostate|May 20, 1999
Macrophage migration inhibitory factor in the human prostate: identification and immunocytochemical localizationF Arcuri, M T del Vecchio, M M de Santi, et al.
International Journal of Cancer|September 9, 1992
Phenotypic overlaps between pleomorphic malignant T-cell lymphomas and mixed-cellularity Hodgkin's diseaseP Tosi, L Leoncini, M T Del Vecchio, et al.
International Journal of Cancer|January 10, 2001
Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinomaL Lusini, S A Tripodi, R Rossi, et al.
International Journal of Cancer|November 1, 1994
Spatial distribution of mitosis, apoptosis and small blood vessels in malignant diffuse follicular-center-cell lymphomas: a nearest-neighbor analysisR Kraft, P Barbini, L Leoncini, et al.
The Journal of Pathology|December 1, 1995
Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomasD Spina, L Leoncini, M T Del Vecchio, et al.
International Journal of Cancer|November 15, 1996
Stage-related differences of mitotic and apoptotic indices, and bcl-2 protein expression in diffusely growing non-Hodgkin's lymphomasD Spina, L Leoncini, T Megha, et al.
British Journal of Cancer|April 18, 2007
Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulationP Correale, A Sciandivasci, C Intrivici, et al.
Pageof 5